Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

Top Analyst Upgrades and Downgrades: Amarin, BofA, Citi, JPMorgan, Liberty SiriusXM, Microsoft, Tesla, TripAdvisor, Twitter, Workday and More

Posted: November 18, 2019 at 8:55 am

Stocks hit new highs on Friday with the Dow Jones industrials closing above 28,000 for the first time and with the S&P 500 up over 3,100, but stocks were looking ...
Read Full Story »

Merrill Lynch Has 5 Stocks to Buy for a 2020 Jump in the ISM Index

Posted: November 14, 2019 at 6:55 am

While the overall economy has remained solid, we have had a slowdown in manufacturing over the past year. Though it certainly hasn’t led to a recession, it has led to ...
Read Full Story »

Vertex Pharmaceuticals and Other Biotech Stocks With Recent Golden Crosses

Posted: August 26, 2019 at 11:55 am

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages. The golden cross typically is seen as a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Baidu, BP, Ciena, Chevron, Cree, Exxon, Home Depot, Medtronic, Nvidia, Urban Outfitters and More

Posted: August 21, 2019 at 9:00 am

Monday's gain and the initial higher open on Tuesday faded into a sell-off as investors dipped back into less risky assets, but Wednesday's major equity indexes were indicated to open ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec, Tilray, Wells Fargo and More

Posted: June 11, 2019 at 8:55 am

Stocks were indicated to open higher yet again on Tuesday, as June has turned into a complete role reversal from May's "sell in May" theme that was winning. Investors need ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Tower, American Water Works, Bank of America, eBay, FedEx, Lululemon, Morgan Stanley, Vale, Verizon and More

Posted: December 12, 2018 at 9:00 am

Stocks were indicated up strong by almost 1% on Wednesday morning for the Dow Jones industrial average, S&P 500 and Nasdaq, quite similar to Tuesday's gap-up open. This follows last ...
Read Full Story »

Major Health Care Catalysts Coming by the End of 2018

Posted: December 8, 2018 at 7:20 am

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AECOM, CyberArk, Dillard’s, Hasbro, Mattel, Newell, Papa John’s, Shopify, Snap, Tesla and More

Posted: August 8, 2018 at 9:10 am

Stocks were indicated to open marginally lower on Wednesday after China matched tariffs in the ongoing trade war. Investors have seen a strong earnings season, with more than 70% of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AT&T, Comcast, Disney, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and More

Posted: July 11, 2018 at 9:05 am

Stocks were indicated handily lower on Wednesday, both in the United States and abroad, based on new trade war fears after President Trump signaled a higher $200 billion targeted ...
Read Full Story »

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

Posted: May 10, 2018 at 10:05 am

While large cap pharmaceutical stocks have had a very solid year despite the rumbling by the administration over drug pricing, many smaller specialty pharmaceuticals have lagged. Despite that underperformance, some ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

Posted: March 19, 2018 at 9:00 am

The market finished higher Friday, finally posting some gains after struggling most of the week with concerns over trade tariffs and the potential for a trade war. The futures are ...
Read Full Story »

Stifel Has 5 Specialty Pharmaceutical 2018 Buys With Massive Upside Potential

Posted: January 4, 2018 at 10:45 am

Despite a roaring market in 2017, in which the S&P 500 was up almost 20% on the year, the specialty pharmaceutical group and biotechs severely underperformed. In addition, the performance ...
Read Full Story »

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Posted: December 31, 2017 at 10:15 am

After a horrible 2015 and 2016, the biotechnology industry finally came back to life in 2017, shrugging off many of the issues that have clouded the waters, especially during the ...
Read Full Story »

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Posted: November 30, 2017 at 10:00 am

With the market looking ready to continue running to all-time highs despite yesterday's selling, many pundits feel this late stage part of the rally is more people trying to get ...
Read Full Story »

ImmunoGen Riding High on Jazz Pharma Deal

Posted: August 30, 2017 at 1:05 pm

ImmunoGen Inc. (NASDAQ: IMGN) announced this week that it has decided to partner with Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate ...
Read Full Story »